NASDAQ:RWLK

ReWalk Robotics Stock Forecast, Price & News

$1.49

-0.01 (-0.67 %)

(As of 08/2/2021 10:45 AM ET)

Add

Compare

Today's Range

$1.48

▼

$1.49

50-Day Range

$1.39

▼

$1.99

52-Week Range

$0.98

▼

$6.00

Volume1,576 shs

Average Volume1.99 million shs

Market Capitalization$68.72 million

P/E RatioN/A

Dividend YieldN/A

Beta3.42

30 days | 90 days | 365 days | Advanced Chart

Receive RWLK News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes wearable robotic exoskeletons for individuals with mobility impairments or other medical conditions in Israel, the United States, Europe, the Asia-Pacific, Latin America, and Africa. It offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for used in the rehabilitation of individuals with lower limb disability due to stroke; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers, institutions, and individuals, as well as through distributors. The company was formerly known as Argo Medical Technologies Ltd. and changed its name to ReWalk Robotics Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.

ReWalk Robotics Appoints Senior Biotech Executive, Jeannine Lynch, as Vice President of Strategy and Market Access
August 2, 2021 | finance.yahoo.com

ReWalk Robotics Insights: Return On Capital Employed
June 21, 2021 | benzinga.com

ReWalk Robotics Reports First Quarter 2021 Financial Results
May 11, 2021 | finance.yahoo.com

ReWalk Robotics Stock Appears To Be Significantly Overvalued
April 10, 2021 | finance.yahoo.com

The ReWalk Robotics (NASDAQ:RWLK) Share Price Is Up 311% And Shareholders Are Delighted
March 8, 2021 | finance.yahoo.com

ReWalk Robotics to Present at the H.C. WAINWRIGHT Global Life Sciences Virtual Conference
March 4, 2021 | finance.yahoo.com

ReWalk Enters Contract with BKK Mobil Oil health insurance fund for the supply of ReWalk exoskeleton to eligible persons with spinal cord injury in Germany
March 2, 2021 | finance.yahoo.com

ReWalk Robotics Announces Closing of $40.0 Million Private Placement Priced At-the-Market
February 26, 2021 | finance.yahoo.com

ReWalk Takes Tumble on News
February 22, 2021 | marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:RWLK
Previous Symbol
CUSIPN/A
CIK1607962
Webwww.rewalk.com
Phone972-4959-0123
Employees49
Year FoundedN/A

Sales & Book Value

Annual Sales$4.39 million
Price / Sales15.65
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.86 per share
Price / Book1.73

Profitability

EPS (Most Recent Fiscal Year)($0.82)
Net Income$-12,980,000.00
Net Margins-246.47%
Return on Equity-40.84%
Return on Assets-32.19%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares46,118,000
Market Cap$68.72 million
Next Earnings Date8/11/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.99 out of 5 stars

Medical Sector

603rd out of 2,221 stocks

Surgical Appliances & Supplies Industry

13th out of 41 stocks

3.5 Analyst's Opinion

Consensus Rating
ReWalk Robotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.50, ReWalk Robotics has a forecasted upside of 133.3% from its current price of $1.50.
Amount of Analyst Coverage
ReWalk Robotics has received no research coverage in the past 90 days.

5.0 Community Rank

Outperform Votes
ReWalk Robotics has received 402 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
ReWalk Robotics has received 127 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
ReWalk Robotics has received 75.99% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about ReWalk Robotics and other stocks. Vote “Outperform” if you believe RWLK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RWLK will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
ReWalk Robotics does not currently pay a dividend.
Dividend Growth
ReWalk Robotics does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ReWalk Robotics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $38,306.00 in company stock.
Percentage Held by Insiders
Only 0.44% of the stock of ReWalk Robotics is held by insiders.
Percentage Held by Institutions
Only 12.89% of the stock of ReWalk Robotics is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for ReWalk Robotics are expected to grow in the coming year, from ($0.27) to ($0.25) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of ReWalk Robotics is -2.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ReWalk Robotics is -2.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ReWalk Robotics has a P/B Ratio of 1.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

ReWalk Robotics (NASDAQ:RWLK) Frequently Asked Questions

Is ReWalk Robotics a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ReWalk Robotics stock.
View analyst ratings for ReWalk Robotics or view top-rated stocks.

What stocks does MarketBeat like better than ReWalk Robotics?

Wall Street analysts have given ReWalk Robotics a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ReWalk Robotics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is ReWalk Robotics' next earnings date?

ReWalk Robotics is scheduled to release its next quarterly earnings announcement on Wednesday, August 11th 2021.
View our earnings forecast for ReWalk Robotics.

How were ReWalk Robotics' earnings last quarter?

ReWalk Robotics Ltd. (NASDAQ:RWLK) posted its quarterly earnings data on Tuesday, May, 11th. The medical device company reported ($0.08) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The medical device company earned $1.32 million during the quarter. ReWalk Robotics had a negative trailing twelve-month return on equity of 40.84% and a negative net margin of 246.47%.
View ReWalk Robotics' earnings history.

How has ReWalk Robotics' stock price been impacted by COVID-19?

ReWalk Robotics' stock was trading at $0.6050 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RWLK shares have increased by 147.9% and is now trading at $1.50.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for RWLK?

1 brokers have issued twelve-month price objectives for ReWalk Robotics' shares. Their forecasts range from $3.50 to $3.50. On average, they anticipate ReWalk Robotics' stock price to reach $3.50 in the next year. This suggests a possible upside of 133.3% from the stock's current price.
View analysts' price targets for ReWalk Robotics or view top-rated stocks among Wall Street analysts.

Who are ReWalk Robotics' key executives?

ReWalk Robotics' management team includes the following people:

Mr. Lawrence J. Jasinski, CEO & Director (Age 64, Pay $555.79k)
Mr. Ori Gon, Chief Financial Officer (Age 39, Pay $303.42k)
Ms. Miri Pariente, VP of Operations, Regulatory & Quality (Age 44)
Mr. Andy Dolan, VP of Marketing & Reimbursement
Ms. Judy Kula, VP of Customer Service, HR & Bus. Affairs
Mr. Ami Kraft, Exec. Advisor to the CEO (Age 78)

Who are some of ReWalk Robotics' key competitors?

Some companies that are related to ReWalk Robotics include Invacare (IVC), United Health Products (UEEC), Lakeland Industries (LAKE), Alpha Pro Tech (APT), Milestone Scientific (MLSS), Surgalign (SRGA), CollPlant Biotechnologies (CLGN), Predictive Oncology (POAI), NanoVibronix (NAOV), Nutriband (NTRB), Myomo (MYO), Allied Healthcare Products (AHPI), Wound Management Technologies (WNDM), Bionik Laboratories (BNKL) and Advanced Biomedical Technologies (ABMT).
View all of RWLK's competitors.

What other stocks do shareholders of ReWalk Robotics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy Partners (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Roper Technologies (ROP).

What is ReWalk Robotics' stock symbol?

ReWalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."

Who are ReWalk Robotics' major shareholders?

ReWalk Robotics' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Cutler Group LP (0.00%).
View institutional ownership trends for ReWalk Robotics.

Which institutional investors are selling ReWalk Robotics stock?

RWLK stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.
View insider buying and selling activity for ReWalk Robotics or view top insider-selling stocks.

How do I buy shares of ReWalk Robotics?

Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ReWalk Robotics' stock price today?

One share of RWLK stock can currently be purchased for approximately $1.50.

How much money does ReWalk Robotics make?

ReWalk Robotics has a market capitalization of $69.18 million and generates $4.39 million in revenue each year. The medical device company earns $-12,980,000.00 in net income (profit) each year or ($0.82) on an earnings per share basis.

How many employees does ReWalk Robotics have?

ReWalk Robotics employs 49 workers across the globe.

What is ReWalk Robotics' official website?

The official website for ReWalk Robotics is www.rewalk.com.

Where are ReWalk Robotics' headquarters?

ReWalk Robotics is headquartered at 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203.

How can I contact ReWalk Robotics?

ReWalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected]

This page was last updated on 8/2/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here